Accueil>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Finafloxacin

Finafloxacin

Catalog No.GC33917

La finafloxacine est un agent antimicrobien fluoroquinolone qui présente une efficacité optimale dans des environnements légèrement acides.

Products are for research use only. Not for human use. We do not sell to patients.

Finafloxacin Chemical Structure

Cas No.: 209342-40-5

Taille Prix Stock Qté
10mM (in 1mL DMSO)
282,00 $US
En stock
1mg
138,00 $US
En stock
5mg
321,00 $US
En stock
10mg
459,00 $US
En stock
50mg
1 379,00 $US
En stock
100mg
1 930,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Finafloxacin is a fluoroquinolone antimicrobial agent that exhibits optimum efficacy in slightly acidic environments. Target: AntibacterialFinafloxacin is a pH-activated fluoroquinolone (belonging to a new 8-cyano subclass) to treat serious bacterial infections associated with an acidic environment, including urinary tract infections (UTIs) and Helicobacter pylori infections. Finafloxacin exhibits optimal efficacy in slightly acidic environments (pH 5.0-6.0), under which other fluoroquinolones lose activity. Finafloxacin is highly selective for bacterial type II topoisomerases, including DNA gyrase and DNA topoisomerase IV. [1]

[1]. McKeage K. Finafloxacin: first global approval. Drugs. 2015 Apr;75(6):687-93.

Avis

Review for Finafloxacin

Average Rating: 5 ★★★★★ (Based on Reviews and 40 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Finafloxacin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.